Why Did Top Scientific Journals Reject This Dr. Bronner’s Ad?

David Bronner, CEO of Dr. Bronner's Magic Soaps, presides over a company with famously wacky product labels.

October 20, 2014 | Source: Mother Jones | by Tom Philpott

For related articles and more information, please visit OCA’s Genetic Engineering page and our Millions Against Monsanto page.

David Bronner, CEO of Dr. Bronner’s Magic Soaps, presides over a company with famously wacky product labels. Sample sentence, from the 18-in-1 Hemp PEPPERMINT soap bottle: “Each swallow works hard to be perfect pilot-provider-teacher-lover-mate, no half-true hate!” But Bronner himself, grandson of the founder (the one with the elaborate prose style), has emerged as a serious, though fun-loving, activist, particularly around pesticides and genetically modified crops, as Josh Harkinson’s recent
Mother Jonesprofile shows.

But apparently, Bronner’s writing on GMOs is too hot for the advertising pages of the English-speaking world’s two most renowned science journals,
Science and Nature-even though a slew of magazines, including
Scientific American,
The New Yorker,
Harper’s,
The Nation,
Harvard, and, yes,
Mother Jones, accepted the Bronner ad. It consists of a short essay, known in publishing as an advertorial, that’s nothing like the wild-eyed rants on his company’s soap bottles. Bronner’s ad (PDF) focuses on how GMO crops have led to a net increase in pesticide use in the United States, citing an analysis by Ramon Seidler, a retired senior staff scientist at the Environmental Protection Agency.  

Bronner wrote his essay in response to Michael Specter’s recent
New Yorker takedown of anti-GMO crusader Vandana Shiva. He first published his critique on
Huffington Post
, and then decided to publish it as an ad in a variety of high-profile magazines, because he felt that
The New Yorker is highly influential among liberal elites, and he wanted to get his dissenting view out, he told me.   

Science was close to accepting it, emails shared with me by Bronner show-an ad sales manager for the American Association for the Advancement of Science, which published the magazine, emailed on September 15 that she would send over paper work “in a bit,” adding that “[a]fter you sign it, I can take your credit card info by phone and submit to accounting.” The price: $9,911.00. But hours later, she wrote back, squashing the deal:

Sorry to say there has [been] a reversal opinion. This has gone up the ladder quite far and our CEO along with the board have come back saying that we cannot accept the ad. We’re concerned about backlash from our members and potentially getting into a battle with the GMO industry.